Skip to main content
. 2020 Jan 25;2020:4620251. doi: 10.1155/2020/4620251

Table 3.

Effects of CE, fractions, and isolated compounds of C. pinnatifida upon tumor necrosis factor-alpha (TNF-α), interleukin-1β (IL-1β), and interleukin-17A (IL-17A) in a murine model of carrageenan-induced pleurisy.

Groups (mg/kg) TNF-α (pg/mL) IL-1β (pg/mL) IL-17A (pg/mL)
Sala 85.05 ± 8.35 115.1 ± 21.72 98.90 ± 5.62
Cga 991.3 ± 2.27 1545.00 ± 170.50 337.00 ± 1.14
CE (50)b 451.10±40.76∗∗ 717.10±17.78∗∗ 148.70±19.85∗∗
Hex (25)b 895.50 ± 50.11 661.30±168.10∗∗ 124.40±69.29∗∗
MeOH (10)b 809.00 ± 110.10 768.00±82.63∗∗ 125.00±43.16∗∗
EtOAc (5)b 458.60±30.16∗∗ 1085.00±66.39∗∗ 192.10 ± 28.31
3,5-diCQA (2.5)b 296.00±110.60∗∗ 310.00±81.82∗∗ 147.20±42.91∗∗
4,5-diCQA (5)b 431.7±67.08∗∗ 365.80±22.10∗∗ 172.40±34.85∗∗
Dex (0.5)b 371.00±58.24∗∗ 243.3±6.00∗∗ 143.80±42.47∗∗
Indo (5)b 415.80±64.96∗∗ 467.8±117.50∗∗ 124.10±40.46∗∗

Crude extract (CE: 50 mg/kg), hexane fraction (Hex: 25 mg/kg), methanol fraction (MeOH: 10 mg/kg), ethyl acetate fraction (EtOAc: 5 mg/kg), 3,5-di-O-E-caffeoylquinic acid (3,5-diCQA: 2.5 mg/kg), and 4,5-di-O-E-caffeoylquinic acid (4,5-diCQA: 5 mg/kg) obtained from C. pinnatifida leaves administered 0.5 h before pleurisy induction. Sal: negative control group, animals treated only with sterile saline (0.95%); Cg: positive control group, animals treated only with carrageenan (1%); Dex: animals treated with dexamethasone (0.5 mg/kg) 0.5 h before pleurisy induction; Indo: animals treated with indomethacin (5 mg/kg) 0.5 h before pleurisy induction. aAdministered by intra-pleural route (i.pl.). bAdministered by intra-peritoneal route (i.p.). Each group represents the mean ± SEM of six animals. P < 0.05 and ∗∗P < 0.01.